Skip to main content

Major Depressive Disorder

People with mood or anxiety disorders demonstrate shared abnormalities in brain regions involved in emotional and cognitive control, according to a meta-analysis of brain scans published online in JAMA Psychiatry.
Deep brain stimulation of the subcallosal cingulate appears to offer sustained antidepressant efficacy and long-term safety for patients with treatment-resistant depression for up to 8 years.
Antidepressant use appears to be safe, according to a systematic umbrella review of 45 meta-analyses spanning more than 1000 observational studies. Researchers published findings from their review online in JAMA Psychiatry.
SAN DIEGO—When added to ongoing treatment, pimavanserin significantly improved sexual function in patients with major depressive disorder, according to study results shared during poster sessions at Psych Congress 2019.
Sertraline eased anxiety symptoms and improved self-reported mental health within 6 weeks in primary care patients with symptoms of depression, according to a study published online in The Lancet Psychiatry.
Psychedelics researcher Robin Carhart-Harris, PhD, who delivered the opening session at Psych Congress 2018, spoke about the compounds at the World Economic Forum Annual Meeting in Davos, Switzerland.
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Listen to Charles Raison, MD, discuss his JAMA Psychiatry study examining the relationship between inflammation and depression.
Back to Top